OLX-10212

N/A

Report date: 2023/12/06 15:57:15
NME

Base Information

Drug NameOLX-10212
Drug Alias NameOLX301A NOLX-10212OLX10212OLX-301A
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > Small Interfering RNA
Mechanisms of ActionRNA interference
TargetsUpdating
Therapy Area/IndicationsWet age-related macular degenerationMacular Degeneration
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesOlix Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesLaboratoires Thea SASThéa Open InnovationOlix Pharmaceuticals Inc
Inactive CompaniesN/A
Active IndicationsWet age-related macular degenerationMacular Degeneration
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A